Monitor for any upcoming corporate events (earnings, data readouts, financing) that may have prompted the coordinated sales. The absence of a 10b5-1 plan increases the likelihood of information-based selling. Next catalyst to watch: any press release or 8-K in the following weeks.
Price Chart
Executive Summary
Two top executives at Spyre Therapeutics (CEO and CFO) sold a combined $377K of stock on the same day (October 1, 2026) at ~$90/share. While the dollar amount is modest relative to the company's market cap, the simultaneous open-market sales by both the CEO and CFO on the same day warrant attention, though the lack of a 10b5-1 plan indication or prior pattern makes the signal ambiguous.
Key Financial Metrics
Key Facts
- CEO Turtle Cameron sold 2,700 shares for $242K on 2026-10-01
- CFO Scott Burrows sold 1,500 shares for $135K on 2026-10-01
- Total insider sales of $377K, all open-market (code S) on the same day
- No 10b5-1 plan indication or prior pattern noted in the filing
Financial Impact
Total insider sales of $377K, representing approximately 0.12% of market cap (assuming ~$326M market cap from prior data). Modest but notable for being a same-day CEO+CFO cluster.
Risk Factors
- Insider sales may signal management's view that the stock is fairly valued or overvalued near $90
- Same-day CEO+CFO sales without a plan raise the risk of adverse material non-public information
- Potential for further insider selling if the stock remains elevated
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-SYRE-1790991031987 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 12, 2026 14d ago | Institutional Cluster | $85.90 | awaiting T+20 | — | $92.91 (+8.16%) |
Oct 9, 2026 17d ago | SC 13D/A | $85.90 | awaiting T+20 | — | $92.91 (+8.16%) |
Oct 7, 2026 19d ago | 8-K | $80.85 | awaiting T+20 | — | $92.91 (−14.92%) |
Oct 6, 2026 20d ago | 424B5 | $80.85 | awaiting T+20 | — | $92.91 (−14.92%) |
Oct 5, 2026 21d ago | Press Release | $80.11 | awaiting T+20 | — | $92.91 (−15.98%) |
Oct 5, 2026 21d ago | 424B5 | $80.11 | awaiting T+20 | — | $92.91 (−15.98%) |
Oct 5, 2026 21d ago | Press Release | $80.11 | awaiting T+20 | — | $92.91 (−15.98%) |
Oct 2, 2026 24d ago | Insider Cluster | $92.72 | awaiting T+20 | — | $92.91 (−0.20%) |
Sep 3, 2026 7w ago | Insider Cluster | $88.98 $92.72 | ▼ −4.20% | ▼ −3.60% | $92.91 (−4.42%) |
Aug 10, 2026 11w ago | Insider Cluster | $102.74 $86.93 | ▲ +15.39% | ▲ +14.33% | $92.91 (+9.57%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers